Hocoma is a pioneering brand in the field of robotic rehabilitation, dedicated to transforming patient care and therapy outcomes. With a focus on neurological and musculoskeletal recovery, Hocoma develops cutting-edge devices that empower patients to regain mobility and independence. Its flagship products, such as Lokomat® for gait training, Armeo® for upper limb rehabilitation, and Erigo® for early mobilization, provide highly personalized therapy experiences that combine advanced robotics with real-time feedback.

The brand is renowned for integrating clinical evidence into every solution, ensuring that healthcare providers can achieve measurable improvements in patient performance. Hocoma’s devices are designed with both therapists and patients in mind, offering intuitive interfaces, adaptive training programs, and safety features that enhance therapy effectiveness. Beyond technology, the brand emphasizes collaboration with the global medical community, supporting research, clinical studies, and training programs that advance rehabilitation science.

By blending innovation, clinical expertise, and patient-centered design, Hocoma has established itself as a trusted partner for rehabilitation centers and hospitals worldwide. The brand continues to lead the industry by expanding access to robotic-assisted therapy and improving quality of life for individuals recovering from injuries, strokes, or neurological disorders.